That means the target will be in its natural intracellular state, which may not be the case when conventional assay-based screening ... a 2022 partnership with MSD (known as Merck & Co in North ...

The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults. The 21-valent ...